BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.86B |
| 2 |
Rivian
RIVN
|
+$3.55B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$2.79B |
| 4 |
Amazon
AMZN
|
+$2.01B |
| 5 |
Netflix
NFLX
|
+$1.39B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JD.com
JD
|
+$2.43B |
| 2 |
KSU
Kansas City Southern
KSU
|
+$1.9B |
| 3 |
NetEase
NTES
|
+$1.73B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.16B |
| 5 |
PayPal
PYPL
|
+$1.1B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.59% |
| 2 | Healthcare | 13.52% |
| 3 | Financials | 12.23% |
| 4 | Consumer Discretionary | 11.23% |
| 5 | Industrials | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1901
Cardlytics
CDLX
$23.6M
| $158M | ﹤0.01% |
239,461
-7,498
| -3% | -$5.73M |
|
1902
Benchmark Electronics
BHE
$2.91B
| $158M | ﹤0.01% |
5,835,778
+184,738
| +3% | +$4.74M |
|
1903
LeMaitre Vascular
LMAT
$2.37B
| $158M | ﹤0.01% |
3,147,424
+31,590
| +1% | +$1.63M |
|
|
CCXI
1904
DELISTED
ChemoCentryx, Inc.
CCXI
| $158M | ﹤0.01% |
4,326,487
-102,067
| -2% | -$3.58M |
|
1905
iHeartMedia
IHRT
$602M
| $157M | ﹤0.01% |
7,474,421
+221,711
| +3% | +$4.7M |
|
1906
STMicroelectronics
STM
$46.5B
| $157M | ﹤0.01% |
3,211,808
+385,671
| +14% | +$18.2M |
|
|
SOLN
1907
DELISTED
The Southern Company
SOLN
| $157M | ﹤0.01% |
2,915,618
+36,091
| +1% | +$1.87M |
|
|
GBT
1908
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $157M | ﹤0.01% |
5,353,056
-418,159
| -7% | -$13M |
|
|
PCGU
1909
DELISTED
PG&E Corporation
PCGU
| $156M | ﹤0.01% |
1,352,220
+16,817
| +1% | +$1.9M |
|
1910
News Corp Class B
NWS
$17.2B
| $156M | ﹤0.01% |
6,939,070
+401,466
| +6% | +$9.2M |
|
|
ARR
1911
Armour Residential REIT
ARR
$2.31B
| $156M | ﹤0.01% |
3,176,940
+241,939
| +8% | +$12.5M |
|
|
NTUS
1912
DELISTED
Natus Medical Inc
NTUS
| $156M | ﹤0.01% |
6,558,137
+126,819
| +2% | +$3.13M |
|
1913
Endava
DAVA
$163M
| $155M | ﹤0.01% |
925,666
+16
| +0% | +$2.48K |
|
|
CCRN
1914
DELISTED
Cross Country Healthcare
CCRN
| $155M | ﹤0.01% |
5,598,613
+64,390
| +1% | +$1.56M |
|
1915
Innoviva
INVA
$1.53B
| $155M | ﹤0.01% |
9,008,758
+164,032
| +2% | +$2.79M |
|
1916
Beyond Meat
BYND
$316M
| $155M | ﹤0.01% |
2,384,701
-74,887
| -3% | -$6.37M |
|
1917
James River Group Holdings
JRVR
$213M
| $155M | ﹤0.01% |
5,383,750
-47,322
| -0.9% | -$1.47M |
|
1918
BridgeBio Pharma
BBIO
$15.7B
| $155M | ﹤0.01% |
9,275,590
-865,721
| -9% | -$36.6M |
|
1919
PennyMac Financial
PFSI
$3.97B
| $155M | ﹤0.01% |
2,214,826
-109,793
| -5% | -$7.25M |
|
1920
Vanda Pharmaceuticals
VNDA
$315M
| $154M | ﹤0.01% |
9,825,375
+123,253
| +1% | +$2.15M |
|
1921
Adaptive Biotechnologies
ADPT
$3.68B
| $153M | ﹤0.01% |
5,469,989
-120,237
| -2% | -$3.69M |
|
1922
Kanzhun
BZ
$7.36B
| $153M | ﹤0.01% |
4,393,652
+783,649
| +22% | +$27.5M |
|
1923
Allison Transmission
ALSN
$9.65B
| $153M | ﹤0.01% |
4,214,224
+15,435
| +0.4% | +$545K |
|
|
DMC
1924
Del Monte Corp
DMC
$1.43B
| $153M | ﹤0.01% |
5,538,120
+138,235
| +3% | +$4.07M |
|
1925
Towne Bank
TOWN
$3.48B
| $153M | ﹤0.01% |
4,834,915
+207,152
| +4% | +$6.6M |
|
Similar funds
BlackRock's Q4 2021 Portfolio in Review
As of Q4 2021, BlackRock held 5,983 positions worth $3.93T, up 10% from $3.57T the previous quarter. Its ten largest holdings account for 20% of the portfolio.
BlackRock's Q4 2021 filing shows 322 new, 3,517 increased, 1,470 reduced and 167 closed positions. Its largest new stake was Rivian: 30,818,728 shares worth $3.2B. The largest sale was JD.com, an estimated $2.43B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q4 2021 buy was Rivian: 30,818,728 shares worth $3.2B.
- BlackRock added most to Microsoft in Q4 2021, an estimated $3.86B increase.
- BlackRock's biggest Q4 2021 reduction was JD.com, cutting an estimated $2.43B.
- BlackRock fully exited Kansas City Southern in Q4 2021, selling an estimated $1.9B.
- BlackRock's ten largest holdings make up 20% of its $3.93T portfolio in Q4 2021.
- BlackRock opened 322 new positions and closed 167 in Q4 2021.
- BlackRock's portfolio value rose 10% quarter-over-quarter to $3.93T.
Based on BlackRock's 13F filing for Q4 2021, filed 10 Feb 2022.